Kwong Lung Enterprise Co., Ltd. (TPEX:8916)
Taiwan · Delayed Price · Currency is TWD 40.20
-0.20 (-0.50%)
Aug 19, 2026, 11:00 AM CST
Kwong Lung Enterprise Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,072 | 7,480 | 8,720 | 8,580 | 7,285 | 5,323 | |
Market Cap Growth | -17.02% | -14.22% | 1.63% | 17.77% | 36.86% | 1.29% |
Enterprise Value | 8,018 | 9,552 | 10,200 | 8,653 | 7,619 | 6,584 |
Last Close Price | 40.40 | 46.33 | 49.87 | 46.39 | 39.79 | 28.74 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.17 | 19.86 | 14.33 | 14.93 | 8.34 | 11.33 |
Forward PE | - | 9.13 | 10.85 | 12.40 | 9.14 | 13.22 |
PS Ratio | 0.74 | 0.88 | 1.11 | 1.11 | 0.71 | 0.66 |
PB Ratio | 1.20 | 1.39 | 1.46 | 1.53 | 1.31 | 1.07 |
P/TBV Ratio | 1.21 | 1.40 | 1.50 | 1.54 | 1.34 | 1.13 |
P/FCF Ratio | 10.47 | 8.04 | - | 8.69 | 5.53 | - |
P/OCF Ratio | 8.59 | 6.59 | 81.96 | 6.82 | 4.58 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.98 | 1.12 | 1.29 | 1.12 | 0.74 | 0.82 |
EV/EBITDA Ratio | 16.99 | 15.68 | 14.66 | 12.09 | 7.05 | 19.94 |
EV/EBIT Ratio | 25.46 | 20.13 | 17.69 | 14.49 | 7.99 | 35.05 |
EV/FCF Ratio | 13.83 | 10.27 | - | 8.76 | 5.79 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.62 | 0.56 | 0.41 | 0.19 | 0.24 | 0.37 |
Debt / EBITDA Ratio | 6.43 | 4.64 | 3.30 | 1.42 | 1.15 | 4.88 |
Debt / FCF Ratio | 5.39 | 3.22 | - | 1.10 | 1.00 | - |
Net Debt / Equity Ratio | 0.38 | 0.33 | 0.23 | -0.07 | -0.05 | 0.09 |
Net Debt / EBITDA Ratio | 4.11 | 2.91 | 1.95 | -0.56 | -0.26 | 1.28 |
Net Debt / FCF Ratio | 3.32 | 1.91 | -5.41 | -0.41 | -0.21 | -0.53 |
Asset Turnover | 0.79 | 0.85 | 0.87 | 0.93 | 1.22 | 1.02 |
Inventory Turnover | 3.11 | 3.47 | 3.15 | 3.29 | 3.68 | 3.38 |
Quick Ratio | 0.64 | 0.65 | 0.69 | 1.36 | 1.20 | 1.13 |
Current Ratio | 1.15 | 1.18 | 1.47 | 2.33 | 2.15 | 2.14 |
Return on Equity (ROE) | 8.62% | 6.63% | 10.48% | 10.33% | 17.39% | 9.87% |
Return on Assets (ROA) | 2.00% | 2.96% | 3.95% | 4.51% | 7.07% | 1.49% |
Return on Invested Capital (ROIC) | 3.48% | 4.87% | 7.53% | 8.80% | 14.46% | 2.90% |
Return on Capital Employed (ROCE) | 5.40% | 7.50% | 8.30% | 9.50% | 15.50% | 3.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.11% | 5.04% | 6.99% | 6.73% | 12.62% | 9.68% |
FCF Yield | 9.55% | 12.44% | -2.88% | 11.51% | 18.07% | -15.09% |
Dividend Yield | 6.17% | 5.40% | 7.22% | 7.76% | 10.05% | 10.44% |
Payout Ratio | 125.95% | 144.38% | 88.89% | 98.55% | 47.87% | 85.21% |
Buyback Yield / Dilution | 0.61% | -0.19% | -0.22% | -0.51% | -0.49% | -0.11% |
Total Shareholder Return | 6.78% | 5.20% | 7.00% | 7.25% | 9.56% | 10.33% |